MODYVANZ

View On IC.GC.CA

ADVERTISED

on 8 Jan 2025

Last Applicant/ Owned by

TEVA Pharmaceutical Industries Limited

Science Based Industries CampusHar Hotzvim, P.O. Box 1142Jerusalem, 91010

Serial Number

2121976 filed on 21^st Jul 2021

Correspondent Address

OSLER, HOSKIN & HARCOURT LLP

Suite 320, World Exchange Plaza100 Queen StreetOttawa,

ONTARIO

K1P1J9

MODYVANZ

Trademark usage description

pharmaceutical preparations for the treatment of multiple sclerosis, lupus nephritis and crohn's disease.

Classification Information

2121976

Trademark

Action Taken	Status
Submitted for opposition 42 on 8^th Jan 2025	Advertised
Submitted for opposition 26 on 16^th Dec 2024	Approved
Submitted for opposition 27 on 16^th Dec 2024	Approval Notice Sent
Submitted for opposition 22 on 6^th Dec 2024	Search Recorded
Submitted for opposition 287 on 6^th Jul 2022	Pre-Assessment Letter Sent
Submitted for opposition 30 on 21^st Jul 2021	Filed
Submitted for opposition 1 on 21^st Jul 2021	Created
Submitted for opposition 31 on 21^st Jul 2021	Formalized